Nuernisha
Alifu†
*a,
Rong
Ma†
b,
Lijun
Zhu
a,
Zhong
Du
b,
Shuang
Chen
b,
Ting
Yan
a,
Gulinigaer
Alimu
a,
Linxue
Zhang
a and
Xueliang
Zhang
*a
aState Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia School of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, 830011, China. E-mail: nens_xjmu@126.com; shuxue2456@126.com
bState Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, Department of Gynecology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
First published on 26th September 2023
Retraction of ‘A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer’ by Nuernisha Alifu et al., J. Mater. Chem. B, 2022, 10, 506–517, https://doi.org/10.1039/D1TB02481G.
The TEM image in the inset in Fig. 1a contains two identical nanoparticles and all nanoparticles are uniform in size and evenly dispersed. An independent expert reviewed this image and concluded that the image was manipulated.
In Fig. S8 there is partial overlap between the two heart images and the two spleen images.
Given the significance of these concerns, the findings presented in this paper are no longer reliable.
The authors were informed about the retraction of the article. Ma Rong responded but did not confirm whether they agreed to retract the article. The other authors have not responded.
Signed: Nuernisha Alifu
Date: 20 September 2023
Retraction endorsed by Michaela Mühlberg, Executive Editor, Journal of Materials Chemistry B
Footnote |
† These authors contributed equally. |
This journal is © The Royal Society of Chemistry 2023 |